GlassScriptPhysician profile
Marieta Branis
NPI 1285849885
$2,656.31
in general payments reported to CMS, 2019-2025
19 companies · $740 in 2025
The $740 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $466 · 2022: $361 · 2023: $614 · 2024: $475 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,828.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $655.24 | 2023-2025 | |
| Daiichi Sankyo INC. | $572.47 | 2021-2023 | Enhertu |
| Astrazeneca Pharmaceuticals LP | $396.46 | 2021-2025 | Lynparza, Enhertu |
| Seagen INC. | $187.85 | 2021-2023 | Tukysa |
| Eisai INC. | $153.23 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $138.77 | 2021-2025 | Keytruda, Lynparza |
| Abbvie INC. | $128.24 | 2024-2025 | |
| Stemline Therapeutics INC. | $90.93 | 2023-2025 | Orserdu |
| Lilly USA, LLC | $62.73 | 2021-2022 | |
| Glaxosmithkline, LLC. | $52.49 | 2021-2024 | Zejula, Jemperli |
| Taiho Oncology, INC. | $52.06 | 2024-2025 | |
| Pfizer INC. | $38.43 | 2023 | |
| Janssen Biotech, INC. | $31.86 | 2025 | Rybrevant |
| Cumberland Pharmaceuticals, INC. | $19.58 | 2024 | Sancuso |
| Beone Medicines USA, INC. | $18.45 | 2025 | Brukinsa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Medicine, INC. | $16.02 | 2022 | |
| Cti Biopharma Corp. | $14.66 | 2023 | Vonjo |
| Immunogen, INC. | $13.71 | 2023 | Elahere |
| Clovis Oncology, INC. | $13.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marieta Branis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.